Participants 115 123 5
melanoma
Participants 134 186 7
Nearly 2000 patients with stage IIB and III melanoma
Participants 697 739 3
patients in E1684, E1690, E1694, and E2696
Participants 819 831 5
713 patients
Participants 1732 1773 3
patients with high-risk resected melanoma
